Navigation Links
Wyeth Donates $100,000 to ASCO Cancer Foundation(R) to Support Cancer Prevention and Care
Date:5/30/2009

initiatives; restrictions on third-party payments for our products; substantial competition in our industry, including from branded and generic products; emerging data on our products and pipeline products; the importance of strong performance from our principal products and our anticipated new product introductions; the highly regulated nature of our business; product liability, intellectual property and other litigation risks and environmental liabilities; the outcome of government investigations; uncertainty regarding our intellectual property rights and those of others; difficulties associated with, and regulatory compliance with respect to, manufacturing of our products; risks associated with our strategic relationships; global economic conditions; interest and currency exchange rate fluctuations and volatility in the credit and financial markets; changes in generally accepted accounting principles; trade buying patterns; the impact of legislation and regulatory compliance; risks and uncertainties associated with global operations and sales; and other risks and uncertainties, including those detailed from time to time in our periodic reports filed with the Securities and Exchange Commission, including our current reports on Form 8-K, quarterly reports on Form 10-Q and annual report on Form 10-K, particularly the discussion under the caption "Item 1A, Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2008, which was filed with the Securities and Exchange Commission on February 27, 2009. The forward-looking statements in this press release are qualified by these risk factors. We assume no obligation to publicly update any forward-looking statements, whether as a result of new information, future developments or otherwise.


'/>"/>
SOURCE Wyeth Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. U.S. and 16 States Join Suits Against Pharmaceutical Giant, Wyeth
2. Wyeth Reports Earnings Results for the 2009 First Quarter
3. Gene Network Sciences Names Former Wyeth President of R&D Robert Ruffolo to SAB
4. Wyeths CONBRIZA Approved in the European Union for Treatment of Postmenopausal Osteoporosis in Women at Increased Risk of Fracture
5. Wyeth Reduces Risk with Dyadem Software
6. Wyeth Submits Marketing Application to FDA for its 13-Valent Vaccine for the Prevention of Pneumococcal Disease in Infants and Toddlers
7. FDA Approves New Indication for Wyeths TYGACIL (tigecycline) for the Treatment of Adult Patients with Community-Acquired Bacterial Pneumonia
8. DRI - the Voice of the Defense Bar Responds to Supreme Court Ruling in Wyeth v. Levine
9. Wyeth Comments on U.S. Supreme Court Ruling in Levine Preemption Case
10. NJLRA Statement on Todays U.S. Supreme Courts Decision in Wyeth v. Levine
11. Wyeth Reports Earnings Results for the 2008 Full Year and Fourth Quarter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... analysis of published studies found that FDG-PET technology ... benign disease in regions where infections like histoplasmosis ... lesions suspicious for cancer could lead to unnecessary ... complications and mortality. , Histoplasmosis and other ... often concentrated in bird droppings and are found ...
(Date:9/23/2014)... 2014 World of Home Fitness is ... Most recently, the gym has been raising money to ... Throughout the year, World of Home Fitness has participated ... , Over the summer, World of Home Fitness raised ... Ageless Fitness program, participants helped feed seniors "one rep ...
(Date:9/23/2014)... As a consumer in today’s world, ... It’s difficult to trust testimonials that are supplied by ... manipulate their customers into saying anything. , Consumer advocacy ... to lack in depth coverage on a particular market ... to fix this issue and focus on exposing the ...
(Date:9/23/2014)... HealthDay Reporter TUESDAY, Sept. ... got paid for providing better care, not ... informed health choices. A new report suggests that,s ... report, from the IMS Institute for Healthcare Informatics in Parsippany, ... to alter the delivery of health care and use of ...
(Date:9/23/2014)... Genomic medicine is rapidly developing, bringing with its ... and optimize prevention and treatment interventions. Genetic ... immunodeficiency virus (HIV) and hepatitis c virus (HPC), ... be used to screen for an individual,s susceptibility ... treatments for addiction. , While there appear to ...
Breaking Medicine News(10 mins):Health News:Study questions accuracy of lung cancer screens in some geographic regions 2Health News:World of Home Fitness Supports Meals on Wheels 2Health News:Consumer Health Reports Debuts Revolutionary Review Website 2Health News:Report Identifies Game Changers for U.S. Health Care 2Health News:Report Identifies Game Changers for U.S. Health Care 3Health News:NYU-Mount Sinai Beth Israel study explores drug users' opinions on genetic testing 2
... anxiety, experts say, , , FRIDAY, May 15 (HealthDay News) -- ... associated with heights, a job interview or getting lost in ... and tension that affects twice as many women as men ... quality of life. , But a new study published in ...
... a vaccine , , FRIDAY, May 15 (HealthDay News) -- ... has yet to run its current course in the ... closed Thursday after dozens of flu-like infections surfaced and ... ventilator, according to published reports. , New York Mayor ...
... LONDON, May 15 Tourist figures are returning to ... major carrier,DialAFlight. Despite continued warnings from the press, governments ... from booking,holidays to ,at-risk, areas of the globe. , ... which carries half a million customers each,year - reports ...
... The Mobile Massage Team ( www.mobilemassageteam.com ), a ... programs, promotional events, and special affairs, today announced that the ... Unites(R) for Living Beyond Breast Cancer ( http://www.lbbc.org ... a.m. to 12:00 p.m. on the steps of the Philadelphia ...
... Paul Capital Healthcare today announced that New York-based partner, ... forms of financing at the 2009 BIO International Convention. ... non-dilutive financing options that can meet the needs of ... and Other Non-traditional Forms of Financing," is scheduled for ...
... Palatin Technologies, Inc. (NYSE Amex: PTN ) announced ... Palatin reported net income of $0.1 million, or $0.00 per basic ... to a net loss of $5.1 million, or $0.06 per basic ... revenues in the quarter ended March 31, 2009 were $5.2 million, ...
Cached Medicine News:Health News:Fear Response May Stem From Protein in Brain 2Health News:Swine Flu Closes 3 Schools in NYC 2Health News:Swine Flu Closes 3 Schools in NYC 3Health News:Swine Flu Closes 3 Schools in NYC 4Health News:Swine Flu Closes 3 Schools in NYC 5Health News:Swine Flu Closes 3 Schools in NYC 6Health News:Swine Flu Closes 3 Schools in NYC 7Health News:Swine Flu Closes 3 Schools in NYC 8Health News:Swine Flu Closes 3 Schools in NYC 9Health News:Swine Flu Closes 3 Schools in NYC 10Health News:DialAFlight Announce Bookings Upsurge After Swine Scare 2Health News:Paul Capital Healthcare to Participate in Panel on Non-Traditional Forms of Financing 2Health News:Palatin Technologies, Inc. Reports Fiscal Year 2009 Third Quarter Results; Teleconference and Webcast to be held on May 15, 2009 2Health News:Palatin Technologies, Inc. Reports Fiscal Year 2009 Third Quarter Results; Teleconference and Webcast to be held on May 15, 2009 3Health News:Palatin Technologies, Inc. Reports Fiscal Year 2009 Third Quarter Results; Teleconference and Webcast to be held on May 15, 2009 4Health News:Palatin Technologies, Inc. Reports Fiscal Year 2009 Third Quarter Results; Teleconference and Webcast to be held on May 15, 2009 5Health News:Palatin Technologies, Inc. Reports Fiscal Year 2009 Third Quarter Results; Teleconference and Webcast to be held on May 15, 2009 6
(Date:9/23/2014)... , September 23, 2014 ... has announced the addition of the  "Large ... to their offering.  ,     ... drug delivery market holds significant potential for ... vials and painful needles to the modern-day ...
(Date:9/23/2014)... , Sept. 23, 2014  MEDIMETRIKS PHARMACEUTICALS ... William Resnick have been elected to ... Mr. Lary, who will serve on ... and investment experience to the Company.  Mr. Lary ... Advisors, LLC, a leading institutional investment firm.  Mr. ...
(Date:9/23/2014)... 2014  KemPharm, Inc., a clinical-stage specialty pharmaceutical ... proprietary new molecular entity (NME) prodrugs, announced today ... from Health Canada to begin clinical trials in ... product candidate KP201 (benzhydrocodone hydrochloride and acetaminophen).  KP201 ... moderate to moderately severe pain. The Health Canada ...
Breaking Medicine Technology:Large Volume Wearable Injectors - 2nd Edition 2Large Volume Wearable Injectors - 2nd Edition 3Large Volume Wearable Injectors - 2nd Edition 4Large Volume Wearable Injectors - 2nd Edition 5Medimetriks Pharmaceuticals, Inc. Welcomes Independent Directors Andrew Lary and William Resnick to its Board of Directors 2KemPharm Receives Health Canada Approval to Begin KP201 Clinical Trials in Canada 2KemPharm Receives Health Canada Approval to Begin KP201 Clinical Trials in Canada 3
Design allows for easy-one hand application to provide support and immobilization of the wrist while preserving finger mobility...
... The Hand and Wrist Cryo/Cuff combines the ... and swelling, and cold to minimize pain. The ... be repositioned for desired hand coverage. ,For added ... and can be removed if a wider range ...
... The Blue Line UNO Splint fits small, ... Softy cushioned two-part design includes both dorsal and ... and extension. Recommended for those experiencing symptoms of ... Ideal for busy clinics - stock one splint ...
... 3-Point® Polycentric Hinged Ulnar Deviation Splint uses ... the hand with ulnar deviation at the ... grasp or pinch. Radial and ulnar polycentric ... unimpeded flexion and extension. Padded, malleable finger ...
Medicine Products: